Literature DB >> 20495969

New multileaf collimator with a leaf width of 5 mm improves plan quality compared to 10 mm in step-and-shoot IMRT of HNC using integrated boost procedure.

Felix Zwicker1, Henrik Hauswald, Simeon Nill, Bernhard Rhein, Christian Thieke, Falk Roeder, Carmen Timke, Angelika Zabel-du Bois, Jürgen Debus, Peter E Huber.   

Abstract

PURPOSE: To investigate whether a new multileaf collimator with a leaf width of 5 mm (MLC-5) over the entire field size of 40 x 40 cm(2) improves plan quality compared to a leaf width of 10 mm (MLC-10) in intensity-modulated radiotherapy (IMRT) with integrated boost for head and neck cancer. PATIENTS AND METHODS: A plan comparison was performed for ten patients with head and neck cancer. For each patient, seven plans were calculated: one plan with MLC-10 and nine beams, four plans with MLC-5 and nine beams (with different intensity levels and two-dimensional median filter sizes [2D-MFS]), and one seven-beam plan with MLC-5 and MLC-10, respectively. Isocenter, beam angles and planning constraints were not changed. Mean values of common plan parameters over all ten patients were estimated, and plan groups of MLC-5 and MLC-10 with nine and seven beams were compared.
RESULTS: The use of MLC-5 led to a significantly higher conformity index and an improvement of the 90% coverage of PTV1 (planning target volume) and PTV2 compared with MLC-10. This was noted in the nine- and seven-beam plans. Within the nine-beam group with MLC-5, a reduction of the segment number by up to 25% at reduced intensity levels and for increased 2D-MFS did not markedly worsen plan quality. Interestingly, a seven-beam IMRT with MLC-5 was inferior to a nine-beam IMRT with MLC-5, but superior to a nine-beam IMRT with MLC-10.
CONCLUSION: The use of an MLC-5 has significant advantages over an MLC-10 with respect to target coverage and protection of normal tissues in step-and-shoot IMRT of head and neck cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20495969     DOI: 10.1007/s00066-010-2103-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets.

Authors:  Andrea Pirzkall; Mark P Carol; Barby Pickett; Ping Xia; Mack Roach; Lynn J Verhey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

2.  Effect of beam number on organ-at-risk sparing in dynamic multileaf collimator delivery of intensity modulated radiation therapy.

Authors:  Richard A Popple; John B Fiveash; Ivan A Brezovich
Journal:  Med Phys       Date:  2007-10       Impact factor: 4.071

3.  A quantitative image quality comparison of four different image guided radiotherapy devices.

Authors:  Julia Stützel; Uwe Oelfke; Simeon Nill
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

4.  Influence of the linac design on intensity-modulated radiotherapy of head-and-neck plans.

Authors:  R Topolnjak; U A van der Heide; G J Meijer; B van Asselen; C P J Raaijmakers; J J W Lagendijk
Journal:  Phys Med Biol       Date:  2006-12-14       Impact factor: 3.609

5.  Intensity modulated radiation therapy with multileaf collimators of different leaf widths: a comparison of achievable dose distributions.

Authors:  Simeon Nill; Thomas Tücking; Marc W Münter; Uwe Oelfke
Journal:  Radiother Oncol       Date:  2005-04-18       Impact factor: 6.280

6.  [Computerized procedures in 3-dimensional radiotherapy planning].

Authors:  A Höss; J Debus; R Bendl; R Engenhart-Cabillic; W Schlegel
Journal:  Radiologe       Date:  1995-09       Impact factor: 0.635

7.  The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy.

Authors:  Tilo Wiezorek; Andrea Schwahofer; Kai Schubert
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

8.  Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis.

Authors:  Diana Steinmann; Bettina Cerny; Johann Hinrich Karstens; Michael Bremer
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

9.  Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.

Authors:  Silke Tribius; Stefanie Kronemann; Yasemin Kilic; Ursula Schroeder; Samer Hakim; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

10.  Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.

Authors:  Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jörn Kalz; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

View more
  14 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

2.  Dosimetric integration of daily mega-voltage cone-beam CT for image-guided intensity-modulated radiotherapy.

Authors:  A Zabel-du Bois; S Nill; S Ulrich; U Oelfke; B Rhein; P Haering; S Milker-Zabel; A Schwahofer
Journal:  Strahlenther Onkol       Date:  2012-01-05       Impact factor: 3.621

3.  New possibilities for volumetric-modulated arc therapy using the Agility™ 160-leaf multileaf collimator.

Authors:  Nadine Blümer; Christian Scherf; Janett Köhn; Eugen Kara; Britta Loutfi-Krauß; Detlef Imhoff; Claus Rödel; Ulla Ramm; Jörg Licher
Journal:  Strahlenther Onkol       Date:  2014-07-25       Impact factor: 3.621

Review 4.  [Radiation-related caries: etiology and possible preventive strategies. What should the radiotherapist know?].

Authors:  R Schweyen; J Hey; W Fränzel; D Vordermark; G Hildebrandt; T Kuhnt
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

5.  Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity.

Authors:  D Rades; T Ulbricht; S G Hakim; S E Schild
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

6.  Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.

Authors:  Dirk Rades; Thekla Meyners; Nadja Kazic; Amira Bajrovic; Volker Rudat; Steven E Schild
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

7.  Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors.

Authors:  M Kocher; H Treuer; M Hoevels; R Semrau; V Sturm; R-P Mueller
Journal:  Strahlenther Onkol       Date:  2012-12-20       Impact factor: 3.621

8.  Effect of the simulated half leaf width of a multileaf collimator on volumetric modulated arc therapy plan quality in hippocampal avoidance whole-brain radiotherapy.

Authors:  Ming-Hsien Li; Li-Jhen Chen; Chih-Chieh Chang; Jo-Ting Tsai; Jang-Chun Lin
Journal:  J Appl Clin Med Phys       Date:  2022-03-03       Impact factor: 2.243

9.  Water-filled balloon in the postoperative resection cavity improves dose distribution to target volumes in radiotherapy of maxillary sinus carcinoma.

Authors:  Qun Zhang; Shi-Rong Lin; Fang He; De-Hua Kang; Guo-Zhang Chen; Wei Luo
Journal:  Chin J Cancer       Date:  2011-11

10.  Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments.

Authors:  Steffi Kantz; Matthias Söhn; Almut Troeller; Michael Reiner; Helmut Weingandt; Markus Alber; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2015-09-02       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.